Bal Pharma has informed about newspaper publication of the notice issued to the Shareholders and Creditors of Bal Pharma (Transferee Company) and its wholly owned subsidiary Golden Drugs (Transferer Company) for the NCLT convened meetings scheduled on 21.12.2023 and published in Financial Express (English) and Vijayavani (Kannada), on 20.11.2023.
The above information is a part of company’s filings submitted to BSE.